William Blair & Company
CBAY

William Blair & Company’s Cymabay Therapeutics CBAY Stock Holding History

William Blair & Company’s Portfolio CBAY Stock Details CBAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-24,888
Closed -$588K – 1863
2023
Q4 		$588K Buy
+24,888
New +$443K ﹤0.01% 1032

Other funds holding CBAY

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

William Blair & Company's CBAY Position: Q1 2024 in Review

William Blair & Company sold out of Cymabay Therapeutics (CBAY) in Q1 2024, closing a stake of 24,888 shares — an estimated $588K sold.

William Blair & Company first reported a position in CBAY in Q4 2023 and held it in 1 quarter. The position peaked at $588K in Q4 2023. 1 fund tracked by Wall St. Rank holds CBAY as of Q1 2024.

  • William Blair & Company reported no remaining Cymabay Therapeutics position as of Q1 2024 after selling out during the quarter.
  • William Blair & Company sold 24,888 Cymabay Therapeutics shares in Q1 2024, an estimated $588K.
  • William Blair & Company first reported a position in Cymabay Therapeutics in Q4 2023 and held it in 1 quarter.
  • William Blair & Company's Cymabay Therapeutics position peaked at $588K in Q4 2023.
  • 1 fund tracked by Wall St. Rank held Cymabay Therapeutics as of Q1 2024.

Based on William Blair & Company's 13F filing for Q1 2024, filed 9 May 2024.